---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-156117"
form_type: "8-K"
ticker: "VNDA"
cik: "0001347178"
company_name: "Vanda Pharmaceuticals Inc."
filed_at: "2024-06-06T23:59:59+00:00"
generated_at: "2026-06-01T05:50:30.794397+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Vanda receives unsolicited acquisition proposal from Cycle Group at $8.00/share

## Summary
- Cycle Group Holdings Ltd. made an unsolicited, non-binding proposal to acquire Vanda for $8.00 per share in cash.
- The proposal is subject to further review; no definitive agreement has been reached.
- Vanda's Board will evaluate the indication with independent financial and legal advisors.
- No shareholder action is required at this time; the Company will not comment further until Board review is complete.
- Cycle Group's offer represents a premium over Vanda's recent closing price (not specified in filing).

## SEC filing metadata
- accession: 0001193125-24-156117
- form_type: 8-K
- ticker: VNDA
- cik: 0001347178
- company_name: Vanda Pharmaceuticals Inc.
- filed_at: 2024-06-06T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1347178/000119312524156117/0001193125-24-156117-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1347178/000119312524156117/d824540d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-156117
- JSON: https://secwatch.observer/filing/0001193125-24-156117.json
- Plain text: https://secwatch.observer/filing/0001193125-24-156117.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.